Browsing Tag
PIV3
1 post
Clover Biopharmaceuticals stock in focus as new RSV re-vaccination data targets a gap GSK has not solved
Clover Biopharmaceuticals says new RSV re-vaccination data beat Arexvy in older adults. Read what this could mean for the adult vaccine market.